4994 — Taisei Lamick Head Quarter & Innovation Balance Sheet
0.000.00%
Annual balance sheet for Taisei Lamick Head Quarter & Innovation, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 5,355 | 5,741 | 5,158 | 5,852 | 4,743 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 6,847 | 6,709 | 7,067 | 7,254 | 7,897 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 16,588 | 17,608 | 17,218 | 17,844 | 18,551 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 13,286 | 11,557 | 12,953 | 13,696 | 13,217 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 31,398 | 31,353 | 32,743 | 34,221 | 35,165 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 8,154 | 7,441 | 8,296 | 8,633 | 8,695 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 8,999 | 7,995 | 8,788 | 9,063 | 9,201 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 22,399 | 23,357 | 23,955 | 25,158 | 25,964 |
| Total Liabilities & Shareholders' Equity | 31,398 | 31,353 | 32,743 | 34,221 | 35,165 |
| Total Common Shares Outstanding |